Therefore, interventions with high doses of folic acid seem to exert tumor progression dependent on upregulation of Angiopoietins and VEGF-C, whereas, low levels of folic acid can induce down-regulation in the VEGF gene and the ratio of ANGPT2/VEGF. The gene discussed is VEGFC; the disease is neoplasm.